Development and validation of a nomogram for predicting survival time and making treatment decisions for clinical stage IA NSCLC based on the SEER database

Development and validation of a nomogram for predicting survival time and making treatment decisions for clinical stage IA NSCLC based on the SEER database

BackgroundThe aim of this study was to establish and validate a nomogram model for accurate prediction of patients’ survival with T1aN0M0 none small cell lung cancer (NSCLC).MethodsThe patients, diagnosed with the stage IA NSCLC from 2004–2015, were identified from the Surveillance, Epidemiology and...

Full description

Bibliographic Details
Main Authors: Bingchen Xu, Ziming Ye, Lianxin Zhu, Chunwei Xu, Mingjian Lu, Qian Wang, Wang Yao, Zhihua Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Medicine
Subjects:
nomogram
SEER
prognosis
NSCLC
treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.972879/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.972879/full

Similar Items